Exactis Innovation featured on personalhealth.ca as part of Mediaplanet special interest campaign.
We are pleased to share an article on Precision Oncology and the Exactis PMT initiative appearing on www.personalhealthnews.ca, and printed in the April 2019 edition of Maclean’s Magazine, as part of a Mediaplanet special interest "Advancements in Cancer Care & Rare Disease" campaign.
"Precision oncology is about selecting the right drug or treatment for the right patient at the right time. Exactis Innovation is a pan-Canadian network helping Canadian cancer patients and their clinicians do just that. Since December 2015, the Personalize My Treatment (PMT)™ initiative has been enrolling cancer patients into a registry that captures the patients’ medical history and the molecular and genomic characteristics of their cancer.The ultimate goal of the network is to increase the number of precision oncology trials in Canada and to match patients in the registry to these trials. Solving the challenges of matching patients with the right treatment in the clinical research setting will not only attract more trials but importantly, will create greater access for Canadian cancer patients to novel targeted treatments."
Read the full article here.
See article in PDF format here.